Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Athersys Inc (NQ: ATHX )

1.320 USD +0.010 (+0.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Athersys Inc

< Previous 1 2 Next >
Notable Monday Option Activity: ATHX, ZG, SHAK
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Athersys Inc (ATHX), where a total of 5,846 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Athersys to Host Third Quarter Financial Results Call
Athersys to Host Q3 Financial Results Call on November 15, 2021 at 4:30 pm ET. 
From Business Wire News Releases
First Week of ATHX December 17th Options Trading
Investors in Athersys Inc (ATHX) saw new options begin trading this week, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags HSTO KTRA TTNP
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ... 
Tags ALZN CNTA ORTX
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ELDN CRXT BNR
From Benzinga
Athersys to Present at 2021 Cell & Gene Meeting on the Mesa Hybrid Conference
Athersys, a late-stage clinical company developing MultiStem cell therapy, will be participating in two events at the Cell & Gene Meeting on the Mesa. 
From Business Wire News Releases
Interesting ATHX Call Options For January 2024
Investors in Athersys Inc (ATHX) saw new options begin trading this week, for the January 2024 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time... 
Tags Stocks
From Market News Video
Notable Tuesday Option Activity: ELS, ATHX, REKR
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Equity Lifestyle Properties Inc (ELS), where a total of 1,945 contracts have traded so far,... 
Tags Stocks
From Market News Video
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Notable Tuesday Option Activity: CLF, ATHX, BRSP
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cleveland-Cliffs Inc (CLF), where a total volume of 242,343 contracts has been... 
Tags Stocks
From Market News Video
Athersys Partner HEALIOS K.K. Completes Enrollment in the TREASURE Study of MultiStem Treatment for Ischemic Stroke
Athersys partner HEALIOS K.K. announces full enrollment of the TREASURE clinical study evaluating MultiStem® cell therapy for stroke patients. 
From Business Wire News Releases
Athersys (ATHX) Q2 2021 Earnings Call Transcript
ATHX earnings call for the period ending June 30, 2021. 
Tags ATHX Market News
From Motley Fool
Athersys: Q2 Earnings Insights
Shares of Athersys (NASDAQ:ATHX) increasedin after-market trading after the company reported Q2 results. Quarterly ... 
Tags ATHX Market News Earnings
From Benzinga
Athersys Reports Second Quarter 2021 Results
Athersys reports Q2 earnings and positive topline ARDS data evaluating MultiStem® from its partner HEALIOS, K.K. The companies advance partnership. 
From Business Wire News Releases
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader ... 
Tags SPPI GOVX APTX
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Nuwellis (NASDAQ:NUWE) shares increased by 5.63% to $4.5 during Friday's after-market session. The market value of their ... 
Tags ERYP CERC BZI/TFM
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Applied Molecular (NASDAQ:AMTI) shares increased by 19.38% to $35.54 during Friday's pre-market session. The ... 
Tags SPPI NVAX BZI/TFM
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PLXP EW BMY
From Benzinga
Athersys Partner HEALIOS K.K. Announces Positive Topline Results of MultiStem for Acute Respiratory Distress Syndrome in the ONE-BRIDGE Study
Healios announces positive topline clinical data from the ONE-BRIDGE study evaluating MultiStem for acute respiratory distress syndrome (ARDS). 
From Business Wire News Releases
Athersys and HEALIOS K.K. Announce Advancement of Their MultiStem Commercial Partnership
Healios and Athersys deepen their partnership and improve the collaboration agreement to enhance preparations for commercial activity in Japan. 
From Business Wire News Releases
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IBB LBPS ONCS
From Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ABCL KRBP AYTU
From Benzinga
Athersys to Host Second Quarter Financial Results Call
Athersys to Host Second Quarter Financial Results Call on August 9th, 2021. 
From Business Wire News Releases
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 29 stocks hit new 52-week lows. Points of Interest: The largest company by ... 
From Benzinga
New Publication Provides Further Clarity of MultiStem's Mechanism of Action on Modulating the Inflammatory Response in Critical Care Indications
Peer-reviewed publication provides evidence of MAPC / MultiStem mechanisms of action on the inflammatory response by promoting Treg differentiation. 
From Business Wire News Releases
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Evaxion Biotech (NASDAQ:EVAX) shares moved upwards by 16.07% to $6.5 during Friday's after-market session. Trading volume for ... 
From Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
From Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
From Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.